Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

538.29 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for... 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Sunday, July 16
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of July 10-14. 
Via Talk Markets
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
Why Eli Lilly Stock Is Rising Today
An acquisition in the lucrative weight loss market is sparking a rally in the drugmaker's shares today. 
Via The Motley Fool
Eli Lilly Unveils A Nearly $2 Billion Deal To Leap Ahead In Weight Loss
The company is hoping to curb the lean muscle mass loss tied to weight-loss drugs. 
Via Investor's Business Daily
S&P 500, Nasdaq Hit Fresh 52-Week Highs As Inflation Fears Ebb; Salesforce, Delta, JPMorgan In Focus: Weekly Review
Salesforce, Delta Air Lines, JPMorgan were key newsmakers. 
Via Investor's Business Daily
Why Eli Lilly Shares Are Surging Today
Eli Lilly And Company (NYSE: LLY)  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
PRGO Stock Alert: Perrigo Climbs on Landmark FDA Birth Control Decision
Perrigo (PRGO) stock is rising on Friday as investors react to the company's over-the-counter birth control pill getting FDA approval. 
Via InvestorPlace
LLY Stock Alert: What to Know as Eli Lilly Acquires Versanis Bio
Eli Lilly (LLY) stock is a hot topic among traders on Friday after the company announced its acquisition of Versanis Bio. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years
Via Benzinga
(LLY) - Analyzing Eli Lilly's Short Interest
Via Benzinga
Expert Ratings for Eli Lilly
Via Benzinga
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
An overweight world is hungry for new treatments. For now, two companies own the market. 
Via Investor's Business Daily
Is Affordable Insulin Available? Survey Reveals Uninsured Americans Paying More Despite Promised Price Reduction
According to a survey conducted by U.S. 
Via Benzinga
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Is the stock a good contrarian buy? 
Via The Motley Fool
Bernie Sanders Doesn't Own Individual Stocks But His Mutual Fund Holdings Include Stakes In Companies He's Criticized, Including Tesla
U.S. Sen. Bernie Sanders has made waves over the years for targeting the ultra-wealthy, with some of the billionaires accumulating their wealth through stock investments. 
Via Benzinga
3 Reasons to Buy Eli Lilly, and 1 Reason to Sell
This drugmaker is a compelling dividend growth play. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
Via Benzinga
The Damaging Report That Sent Weight-Loss Kingpins Novo Nordisk, Eli Lilly Into A Tailspin
Most patients aren't taking Wegovy or other weight loss drugs for long periods of time. 
Via Investor's Business Daily
Eli Lilly Unusual Options Activity For July 10
Via Benzinga
The 7 Best Value Stocks to Buy in July
High potential value stocks offer investors growth and relative stability that many stocks simply cannot right now. 
Via InvestorPlace
Check Out What Whales Are Doing With LLY
Via Benzinga
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
The FDA fully approved Biogen Inc.’s (NASDAQ: BIIB) Alzheimer’s treatment Leqembi on Thursday, becoming the first Alzheimer’s antibody treatment to reach full approval. 
Via Benzinga
Investors Seek Improved Weight-Loss Drugs: Companies Forge Ahead In Developing Nausea-Free Alternatives To Wegovy
Novo Nordisk A/S's (NYSE: NVO) hugely popular Weight-loss drug Wegovy has helped people achieve the goal of shedding weight, but many have discontinued it due to severe nausea and side effects. 
Via Benzinga
After Legal Action Against Wellness Clinics, Novo Nordisk Accuses Pharmacies Over Illegal Sale Of Semaglutide-Based Products
Novo Nordisk A/S (NYSE: NVO) has reportedly filed lawsuits against TruLife Pharmacy, Brooksville Pharmaceuticals, and WellHealth Inc in Florida federal court, accusing the pharmacies of illegally... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Biotech Blues: Stay Balanced Through July Earnings Season
Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts. 
Via Talk Markets
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
Cassava Sciences (SAVA) stock is down 11% on underwhelming results from its Phase 3 clinical trials for its Alzheimer's treatment. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.